|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2700 CAD | -1.82% |
|
+5.88% | +5.88% |
| 11-20 | Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 11-20 | Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025 |
Business description: Vext Science, Inc.
Sales by Activity: Vext Science, Inc.
| Fiscal Period: December | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
Cultivation, Manufacturing, Distribution and Sale of Cannabis | - | - | - | 34.81M | 36M |
Services and Products Relating to Cannabis for Medical Purposes | 25.19M | - | - | - | - |
Geographical breakdown of sales: Vext Science, Inc.
| Fiscal Period: December | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
United States | 25.19M | 37.24M | 35.41M | 34.81M | 36M |
Executive Committee: Vext Science, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Offenberger
CEO | Chief Executive Officer | - | 17/02/2020 |
Trevor Smith
DFI | Director of Finance/CFO | - | 24/08/2023 |
Jonathan Ross
IRC | Investor Relations Contact | - | - |
Nalee Pham
HRO | Human Resources Officer | - | - |
Composition of the Board of Directors: Vext Science, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Mark Opzoomer
CHM | Chairman | 69 | 19/08/2024 |
David Johns
BRD | Director/Board Member | 66 | 14/12/2022 |
Jason Nguyen
CHM | Chairman | 45 | 10/12/2015 |
Eric Offenberger
BRD | Director/Board Member | - | 17/02/2020 |
Spiro Phanos
BRD | Director/Board Member | - | 14/12/2023 |
Terry Creighton
BRD | Director/Board Member | - | 14/12/2023 |
Company details: Vext Science, Inc.

Medical Farming
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.82% | +5.88% | +58.82% | +8.00% | 48.72M | ||
| +72.76% | -.--% | -41.57% | - | 578M | ||
| +0.90% | -6.67% | +0.90% | -56.59% | 217M | ||
| -4.23% | +4.62% | +70.00% | -50.72% | 138M | ||
| -3.17% | 0.00% | +117.86% | +103.33% | 126M | ||
| -2.52% | -3.70% | +80.18% | -23.87% | 116M | ||
| Average | +10.32% | +0.02% | +47.70% | -3.97% | 203.93M | |
| Weighted average by Cap. | +33.41% | -0.78% | +10.48% | -13.39% |
Sector
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2700CAD
Average target price
0.6750CAD
Spread / Average Target
+150.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VEXT Stock
- Company Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















